Balusu Pharma Private Limited
About Balusu Pharma Private Limited
Data last updated:
Balusu Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 January 2017.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017PTC114179. Its GSTIN is 36AAHCB0570E1Z0 (Telangana).
The company had an authorised share capital of ₹25 Lakh and a paid-up capital of ₹20.5 Lakh. It was led by directors including Padma Ramani Balusu and Balusu Keerthi.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at D – 411 Kanchanjunga Block Aditya Enclave Ameerpet, Hyderabad, Telangana, India – 500038.
As per the financials filed for FY 2023, the company reported a revenue of ₹71,054, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹25.61 Lakh and EBITDA of -₹25.49 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 62% over five years.
Company details
Contact details
Balusu Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD – 411 Kanchanjunga Block Aditya Enclave Ameerpet, Hyderabad, Telangana, India – 500038
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Balusu Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Balusu Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Balusu Pharma Private Limited
FY 2023 filings availableBalusu Pharma Private Limited reported revenue of ₹71,054 (up 166% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 166% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 62%. EBITDA fell 147% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹25.49 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹25.61 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Balusu Pharma Private Limited, buy the company report.
Board of directors of Balusu Pharma Private Limited
Balusu Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Padma Ramani Balusu | Director | 23 Jan 2017 | 9 Years 9 Months | As last reported |
| Balusu Keerthi | Director | 01 Feb 2017 | 9 Years 8 Months | As last reported |
| Balusu Deepthi | Director | 23 Jan 2017 | 9 Years 9 Months | As last reported |
Auditor
Balusu Pharma Private Limited is audited by V D N R & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V D N R & ASSOCIATES | FY 2020 | 011251S |
Shareholding
The shareholding of Balusu Pharma Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Balusu Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Balusu Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Balusu Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Balusu Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCB0570E1Z0 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Balusu Pharma Private Limited, buy the company report.
Recent activity
Balusu Pharma Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Vankineni Sai Sudhakar ceased to be Director on 27 Mar 2017.
Frequently asked questions
Balusu Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Balusu Pharma was a private limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 23 January 2017 and is registered under CIN U24304TG2017PTC114179. The company has been struck off by the Registrar of Companies and is no longer operational.
Balusu Pharma had 3 directors:
- Padma Ramani Balusu - Director
- Balusu Keerthi - Director
- Balusu Deepthi - Director
The CIN (Corporate Identification Number) of Balusu Pharma is U24304TG2017PTC114179. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Balusu Pharma is at D – 411 Kanchanjunga Block Aditya Enclave Ameerpet, Hyderabad, Telangana, India – 500038.
Balusu Pharma was incorporated on 23 January 2017. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Balusu Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Balusu Pharma is 36AAHCB0570E1Z0, registered in Telangana.
Balusu Pharma operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Vankineni Sai Sudhakar ceased to be Director on 27 Mar 2017. Balusu Keerthi was appointed as Director on 01 Feb 2017. Balusu Deepthi was appointed as Director on 23 Jan 2017. Balusu Pharma has 4 board changes on record in total.